Japan's health ministry plans to deliver a Moderna vaccine targeting the BA.5 Omicron subvariant of the coronavirus, following the delivery of a similar vaccine made by Pfizer.
The ministry has approved Moderna's BA.5 vaccine. It says the vaccine is expected to be effective against the Omicron subvariant.
The ministry plans to send about 3 million doses to municipalities across the country from the week starting November 28 to late December.
In Japan, vaccines against the Omicron BA.1 subvariant were rolled out in September. They are made by Pfizer and Moderna. Pfizer's vaccine targeting the BA.5 has been available since October.
The health ministry says some 102 million vaccine doses targeting the Omicron variant are expected to be delivered to municipalities by the end of the year.
The latest government data shows that about 8.58 million people, or 6.8 percent of the population, have received such vaccines.
The ministry has approved Moderna's BA.5 vaccine. It says the vaccine is expected to be effective against the Omicron subvariant.
The ministry plans to send about 3 million doses to municipalities across the country from the week starting November 28 to late December.
In Japan, vaccines against the Omicron BA.1 subvariant were rolled out in September. They are made by Pfizer and Moderna. Pfizer's vaccine targeting the BA.5 has been available since October.
The health ministry says some 102 million vaccine doses targeting the Omicron variant are expected to be delivered to municipalities by the end of the year.
The latest government data shows that about 8.58 million people, or 6.8 percent of the population, have received such vaccines.
Similar Readings (5 items)
Japan to provide Omicron vaccines to public starting October
Pfizer applies to use updated vaccine for younger children in Japan
Japan may move up Omicron vaccine rollout to September
Japan approves coronavirus vaccine aimed at Omicron
Govt. to introduce new system for prefectures to combat BA.5 subvariant
Summary
Japan's Health Ministry plans to distribute 3 million doses of Moderna's BA.5 Omicron subvariant vaccine starting from November 28, in addition to the existing Pfizer vaccine. The ministry has approved this vaccine and believes it will be effective against the BA.5 subvariant. The ministry aims to
Statistics
146
Words1
Read CountDetails
ID: b8685f75-bad2-472c-b93a-846030da429a
Category ID: nhk
URL: https://www3.nhk.or.jp/nhkworld/en/news/20221107_34/
Date: Nov. 7, 2022
Created: 2022/11/08 07:22
Updated: 2025/12/09 11:51
Last Read: 2022/11/08 10:15